SAR-103168

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSAR-103168
Drug Alias NameSAR-103168
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitorsSignal transducer and activator of transcription 5A inhibitors
TargetsProtein kinasesSignal transducer and activator of transcription 5A
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A